Year

IP Cases — 2024

6,517 decisions across all jurisdictions

By type: patent 5899 trademark 584 copyright 19 design 15

Page 3 of 218 · 6,517 total

patent · Dec 30, 2024

Google LLC et al. v.Mullen Industries LLC

· IPR2025-00368

The Director denied requests for review in multiple IPR proceedings involving Google and Mullen Industries. The decision affirms the prior denial of institution across several patent challenges.

patent · Dec 30, 2024

Google LLC et al. v.Mullen Industries LLC

· IPR2025-00367

The Director denied requests for review in multiple IPR proceedings involving Google and Mullen Industries. This decision affirms the prior denial of institution, meaning trial will not proceed on these patents.

patent · Dec 30, 2024

Google LLC et al. v.Mullen Industries LLC

· IPR2025-00366

The Director denied requests for review in multiple IPR proceedings involving Google and Mullen Industries regarding patent 11234117. This decision maintains the prior institution decisions across several related cases.

patent · Dec 30, 2024

Google LLC et al. v.Mullen Industries LLC

· IPR2025-00365

The Director denied requests for review in multiple IPR proceedings involving Google and Mullen Industries. The decision affirms the prior institution decisions across several patents.

patent instituted · Dec 30, 2024

Tesla, Inc. v.Intellectual Ventures II

· IPR2025-00339

Tesla, Inc. successfully secured institution at the PTAB against Intellectual Ventures II LLC regarding its digital imaging patents (7916180). The Board found a reasonable likelihood of prevailing on all 16 challenged claims based on obviousness grounds (35 U.S.C. § 103).

patent LITIGATION · Dec 27, 2024

Microsoft Corporation v.Suinno Mobile & AI Technologies Licensing Oy

Paris (FR) Central Division - Seat · UPC-001072

Microsoft Corporation filed an application requesting that Suinno Mobile & AI Technologies Licensing Oy be ordered to provide additional security for legal costs of at least EUR 500,000 (alternatively EUR 300,000), on top of the EUR 300,000 security already ordered by the Court. The Court characterized the request as one to modify the existing security by increasing its amount, and after reviewing the arguments, dismissed the application, finding that the new circumstances cited by Microsoft did not warrant a reassessment of the adequacy of the security already ordered.

patent LITIGATION · Dec 27, 2024

Netgear Inc., Netgear Deutschland GmbH, Netgear International Limited v.Huawei Technologies Co. Ltd.

Munich (DE) Local Division · UPC-001071

This is a procedural order from the Local Division Munich in a declaration of non-infringement action concerning European Patents Nos. 3 678 321 and 3 611 989. The order addresses Netgear's request to incorporate a license agreement between Huawei and Qualcomm (previously filed as Annex K68 in related infringement proceedings) into the present case file, and the proposal to assign the technically qualified judge Patrice Vidon from a related proceeding. Both parties consented to both requests, and the Rapporteur granted them.

patent LITIGATION · Dec 27, 2024

Ona Patents SL v.Google Ireland Limited & Google Commerce Limited

Düsseldorf (DE) Local Division · UPC-001070

In a patent infringement action concerning EP 2 263 098 B1 before the Düsseldorf Local Division, the Defendants (Google Ireland Limited and Google Commerce Limited) requested security for legal costs under Rule 158 RoP, arguing that the Claimant (Ona Patents SL) lacked the financial resources to cover any potential cost order. The Court granted the request in part, ordering the Claimant to provide security of EUR 500,000 within six weeks of service of the order, finding that the Claimant had failed to substantiate its financial position despite the Defendants presenting credible concerns.

patent LITIGATION · Dec 27, 2024

Suinno Mobile & AI Technologies Licensing Oy v.Microsoft Corporation

Paris (FR) Central Division - Seat · UPC-001069

The applicant, Suinno Mobile & AI Technologies Licensing Oy, sought review of a security for costs order of EUR 300,000 imposed against it in its infringement action against Microsoft Corporation, requesting reduction to EUR 100,000 based on its subsequent reduction of damages claimed. The Court of First Instance dismissed the application, holding that the reduction in damages claimed was immaterial to the value of the proceedings, which reflects the claimant's objective interest at the time of filing, and that the applicant's other arguments constituted a critique of the original order that could only be raised on appeal.

patent LITIGATION · Dec 27, 2024

Sumi Agro Limited and Sumi Agro Europe Limited v.Syngenta Limited

Luxembourg (LU) · UPC-001068

This is an order from the Court of Appeal concerning a request by Syngenta to be relieved from translating Exhibit FF25 (filed in German) attached to its Statement of response in appeal proceedings related to European Patent EP 2 152 073. Sumi Agro, the appellant, left the matter to the discretion of the Court. The judge-rapporteur held that no translation of Exhibit FF25 was necessary.

patent LITIGATION · Dec 27, 2024

Ona Patents SL v.Apple Inc., Apple Distribution International Ltd., Apple Retail Germany B.V. & Co. KG, Apple GmbH, and Apple Retail France EURL

Düsseldorf (DE) Local Division · UPC-001067

The defendants in a patent infringement action concerning EP 2 263 098 B1 requested that the claimant, Ona Patents SL, provide security for legal costs under Rule 158 RoP. The Düsseldorf Local Division found the request well-founded, holding that the claimant, a recently founded entity with minimal share capital and no apparent financial reserves, failed to substantiate its ability to bear potential costs. The court ordered the claimant to provide security of EUR 500,000 within six weeks, rejecting the defendants' request for EUR 1.012 million and a one-week deadline.

patent · Dec 27, 2024

Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.

· PGR2025-00009

Merck has filed a post‑grant review petition challenging Halozyme’s enzyme patent, arguing the claims lack adequate written description and enablement. The reply emphasizes functional language and the impossibility of testing the claimed 1,059+ PH20 variants.

patent · Dec 27, 2024

Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.

· PGR2025-00009

Merck defends its PH20 enzyme patent in a PTAB Director Review proceeding, arguing that the claims satisfy §112 written description and enablement and that Halozyme's claim‑construction objections are unfounded. The petitioner also contends that Fintiv factors do not justify discretionary denial.

patent · Dec 27, 2024

Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.

· PGR2025-00009

Halozyme seeks Director Review to overturn the PTAB’s institution of a post‑grant review of its ’035 enzyme patent. The petition contends the Board mis‑interpreted claim language and mis‑applied eligibility standards, and argues that Fintiv factors demand denial of institution.

patent · Dec 27, 2024

Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.

· PGR2025-00009

Halozyme has sought a Director Review of the PGR, and Merck has 5 business days to file a brief response without new evidence.

patent · Dec 27, 2024

Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.

· PGR2025-00009

Court decision.

patent denied · Dec 27, 2024

Google LLC et al. v.Pegasus Wireless Innovation LLC

· IPR2025-00291

The PTAB Director denied Google and other petitioners' request for review of the institution denial in several IPRs, including the case involving Pegasus Wireless Innovation's patent 10,594,460.

patent denied · Dec 27, 2024

Google LLC et al. v.Pegasus Wireless Innovation LLC

· IPR2025-00291

Google’s request for a Director Review of the PTAB’s denial to institute an IPR against Pegasus Wireless Innovation’s patent was rejected. The Board found the petitioners offered no statutory basis and raised new arguments, affirming the Director’s Fintiv analysis as reasonable.

patent · Dec 27, 2024

Google LLC et al. v.Pegasus Wireless Innovation LLC

· IPR2025-00291

Google and other U.S. carriers have filed a petition for Director Review, challenging the PTAB’s discretionary denial of institution for IPR2025-00291 concerning patent 10,594,460. They argue the Board misapplied Fintiv factors, retroactively changed policy, and violated due process. The petition seeks to have the denial vacated and the IPR instituted.

patent · Dec 27, 2024

Biofrontera Incorporated et al. v.Sun Pharmaceutical Industries, Inc.

· IPR2025-00287

Biofrontera has filed a rehearing request challenging the Board’s denial to institute an IPR on Sun Pharmaceutical’s photodynamic therapy patent, arguing the claims are highly vulnerable and that institution would prevent inconsistent rulings.

patent denied · Dec 27, 2024

Biofrontera Incorporated et al. v.Sun Pharmaceutical Industries, Inc.

· IPR2025-00287

The USPTO denied Biofrontera's request for rehearing of the decision that refused to institute its IPR against Sun Pharmaceutical's patent 11,446,512. The Board affirmed the discretionary denial, leaving the patent unchallenged.

patent denied · Dec 27, 2024

Google LLC et al. v.Truesight Communications LLC

· IPR2025-00025

The PTAB denied Samsung's petition for inter partes review of Truesight's '803 patent covering kiosk‑based media distribution. The Board applied the Fintiv discretionary factors and concluded that denying institution best served efficiency given the parallel district‑court litigation.

patent denied · Dec 27, 2024

Google LLC et al. v.Truesight Communications LLC

· IPR2025-00025

Samsung’s petition to invalidate Truesight’s virtual SD‑card patent was denied by the PTAB, which exercised its discretion under § 314(a) after weighing the six Fintiv factors and finding the parallel district‑court litigation outweighed the petition’s merits.

patent · Dec 27, 2024

Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.

· PGR2025-00009

Merck has filed a Post‑Grant Review petition challenging Halozyme’s U.S. Patent 12,123,035 covering PH20 hyaluronidase mutants. The petition asserts lack of written description, lack of enablement, and obviousness of the claims. The Board has yet to decide whether to institute the trial.

patent · Dec 27, 2024

Full-Metal-Power B.V. v.InFocus Downhole Solutions USA LLC

· IPR2025-00391

Full-Metal-Power B.V. has filed an IPR petition challenging all 19 claims of Infocus Downhole Solutions' 2020 patent on downhole progressive cavity tools, asserting obviousness over multiple foreign and U.S. references.

patent · Dec 27, 2024

Google LLC et al. v.Pegasus Wireless Innovation LLC

· IPR2025-00291

Google and its affiliates have filed an IPR petition seeking to invalidate all twelve claims of Pegasus Wireless Innovation's 5G frequency‑hopping patent, arguing that the claims are obvious or anticipated over multiple prior‑art references. The petition also argues the Board should not deny the filing under discretionary statutes.

patent · Dec 27, 2024

Biofrontera Incorporated et al. v.Sun Pharmaceutical Industries, Inc.

· IPR2025-00287

Biofrontera has filed an IPR petition seeking to invalidate eight claims of Sun Pharma’s photodynamic‑therapy device patent, arguing obviousness over Lundahl, Larsen, Hente and Perutz. The petition argues the prior art was not previously considered and that the Board should not deny the petition under §325(d) or Fintiv.

patent · Dec 27, 2024

Full-Metal-Power B.V. v.InFocus Downhole Solutions USA LLC

· IPR2025-00391

Full-Metal-Power B.V. filed a corrected exhibit set for its IPR challenge to InFocus Downhole Solutions' U.S. Patent 10,676,992, addressing labeling errors.

patent · Dec 27, 2024

Google LLC et al. v.Truesight Communications LLC

· IPR2025-00025

Google and Samsung have filed an IPR petition seeking to invalidate claims 1‑19 of Truesight’s ‘879 patent covering V‑chip‑based parental controls. The petition alleges obviousness over prior art references Sullivan, Leung, and Craner and argues that discretionary denial is unwarranted.

patent instituted · Dec 27, 2024

Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.

· PGR2025-00009

The PTAB instituted the PGR petition challenging Halozyme's patent covering modified PH20 polypeptides. The Board found that the claims were not sufficiently supported by the specification regarding enablement and obviousness, despite Petitioner's arguments about the genus size.

Arctic Invent — IP Strategy

Facing a similar IP matter?

Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.

Consult our team →